Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DS-1040b with Aspirin in Healthy Subjects
NCT02071004Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2014
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DS1040b in ischemic stroke, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Bleeding time. Started Jan 2014; status: completed.
02
Drugs
DS1040b
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02071004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071004.